179 related articles for article (PubMed ID: 37866559)
21. Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy.
Dinakar YH; Karole A; Parvez S; Jain V; Mudavath SL
Life Sci; 2022 Dec; 310():121133. PubMed ID: 36306866
[TBL] [Abstract][Full Text] [Related]
22. Hybrid membrane camouflaged copper sulfide nanoparticles for photothermal-chemotherapy of hepatocellular carcinoma.
Ji B; Cai H; Yang Y; Peng F; Song M; Sun K; Yan F; Liu Y
Acta Biomater; 2020 Jul; 111():363-372. PubMed ID: 32434082
[TBL] [Abstract][Full Text] [Related]
23. A dual-targeting strategy for enhanced drug delivery and synergistic therapy based on thermosensitive nanoparticles.
Wang M; You C; Gao Z; Wu H; Sun B; Zhu X; Chen R
J Biomater Sci Polym Ed; 2018 Aug; 29(11):1360-1374. PubMed ID: 29611463
[TBL] [Abstract][Full Text] [Related]
24. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
Gupta A; Kushwaha SS; Mishra A
Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
[TBL] [Abstract][Full Text] [Related]
25. pH- and NIR light responsive nanocarriers for combination treatment of chemotherapy and photodynamic therapy.
Wang S; Yang W; Cui J; Li X; Dou Y; Su L; Chang J; Wang H; Li X; Zhang B
Biomater Sci; 2016 Feb; 4(2):338-45. PubMed ID: 26623461
[TBL] [Abstract][Full Text] [Related]
26. A Photo-Activated Continuous Reactive Oxygen Species Nanoamplifier for Dual-Dynamic Cascade Cancer Therapy.
Zhang X; Zhang X; Guo H; Jia S; Li Y; Xing S; Chang J; Wang S
Adv Healthc Mater; 2023 Nov; 12(28):e2301469. PubMed ID: 37571991
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in dual-ligand targeted nanocarriers for cancer therapy.
Khan N; Ruchika ; Dhritlahre RK; Saneja A
Drug Discov Today; 2022 Aug; 27(8):2288-2299. PubMed ID: 35439614
[TBL] [Abstract][Full Text] [Related]
28. Engineering Persistent Luminescence Nanoparticles for Biological Applications: From Biosensing/Bioimaging to Theranostics.
Sun SK; Wang HF; Yan XP
Acc Chem Res; 2018 May; 51(5):1131-1143. PubMed ID: 29664602
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
[TBL] [Abstract][Full Text] [Related]
30. The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer.
Lee WH; Loo CY; Leong CR; Young PM; Traini D; Rohanizadeh R
Expert Opin Drug Deliv; 2017 Aug; 14(8):937-957. PubMed ID: 27759437
[TBL] [Abstract][Full Text] [Related]
31. NIR-triggered high-efficient photodynamic and chemo-cascade therapy using caspase-3 responsive functionalized upconversion nanoparticles.
Zhao N; Wu B; Hu X; Xing D
Biomaterials; 2017 Oct; 141():40-49. PubMed ID: 28666101
[TBL] [Abstract][Full Text] [Related]
32. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732
[TBL] [Abstract][Full Text] [Related]
33. Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapy.
Lei W; Yang C; Wu Y; Ru G; He X; Tong X; Wang S
J Nanobiotechnology; 2022 Jan; 20(1):45. PubMed ID: 35062958
[TBL] [Abstract][Full Text] [Related]
34. Efficient, enzyme responsive and tumor receptor targeting gelatin nanoparticles decorated with concanavalin-A for site-specific and controlled drug delivery for cancer therapy.
Vaghasiya K; Ray E; Singh R; Jadhav K; Sharma A; Khan R; Katare OP; Verma RK
Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():112027. PubMed ID: 33812642
[TBL] [Abstract][Full Text] [Related]
35. Intracellularly Acid-Switchable Multifunctional Micelles for Combinational Photo/Chemotherapy of the Drug-Resistant Tumor.
Wang T; Wang D; Yu H; Wang M; Liu J; Feng B; Zhou F; Yin Q; Zhang Z; Huang Y; Li Y
ACS Nano; 2016 Mar; 10(3):3496-508. PubMed ID: 26866752
[TBL] [Abstract][Full Text] [Related]
36. Surface engineered nanocarriers for the management of breast cancer.
Nitheesh Y; Pradhan R; Hejmady S; Taliyan R; Singhvi G; Alexander A; Kesharwani P; Dubey SK
Mater Sci Eng C Mater Biol Appl; 2021 Nov; 130():112441. PubMed ID: 34702526
[TBL] [Abstract][Full Text] [Related]
37. Recognition Sites for Cancer-targeting Drug Delivery Systems.
Guan S; Zhang Q; Bao J; Hu R; Czech T; Tang J
Curr Drug Metab; 2019; 20(10):815-834. PubMed ID: 31580248
[TBL] [Abstract][Full Text] [Related]
38. Targeted Delivery of Functionalized Upconversion Nanoparticles for Externally Triggered Photothermal/Photodynamic Therapies of Brain Glioblastoma.
Tsai YC; Vijayaraghavan P; Chiang WH; Chen HH; Liu TI; Shen MY; Omoto A; Kamimura M; Soga K; Chiu HC
Theranostics; 2018; 8(5):1435-1448. PubMed ID: 29507632
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in active targeting of nanomaterials for anticancer drug delivery.
Dutta B; Barick KC; Hassan PA
Adv Colloid Interface Sci; 2021 Oct; 296():102509. PubMed ID: 34455211
[TBL] [Abstract][Full Text] [Related]
40. Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy.
Kim Y; Uthaman S; Pillarisetti S; Noh K; Huh KM; Park IK
Acta Biomater; 2020 May; 108():273-284. PubMed ID: 32205212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
